PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25854427-5	2015	Following fractionation of the insulin-treated cells into cytosol and membrane fractions, phosphorylated TCTP at its Ser residue (p-Ser-TCTP) was detected exclusively in the cytosolic part and not in the membrane fraction.	Phosphoserine	130-135	insulin	Homo sapiens	31-38	
31347216-0	2019	Dephosphorylation of clustered phosphoserine residues in human Grb14 by protein phosphatase 1 and its effect on insulin receptor complex formation.	Phosphoserine	31-44	insulin	Homo sapiens	112-119	
9493129-5	1998	These effects of insulin were completely blocked by cyclosporin-A, an inhibitor of protein phosphatase type 2B (PP2B) which dephosphorylates phospho-tyrosine in addition to phosphoserine/threonine, but not by okadaic acid, an inhibitor of protein phosphatase type 1 and 2A.	Phosphoserine	173-186	insulin	Homo sapiens	17-24	
12107176-4	2002	MALDI-TOF mass spectrometry revealed the protein to be ATP-citrate lyase, suggesting that the two phosphospecific antibodies recognize phosphoserine 454, a previously reported insulin- and isoproterenol-stimulated ATP-citrate lyase phosphorylation site.	Phosphoserine	135-148	insulin	Homo sapiens	176-183	
8216295-0	1993	Anti-phosphoserine and anti-phosphothreonine antibodies modulate autophosphorylation of the insulin receptor but not EGF receptor.	Phosphoserine	5-18	insulin	Homo sapiens	92-99	
7542920-6	1995	Two-dimensional thin-layer tryptic mapping of the phosphorylated insulin receptor/insulin-stimulated insulin receptor serine kinase preparation or of insulin receptor phosphorylated in human Hep G2 cells yielded two major peptides, called S1 and S2, that ran as a pair of closely migrating spots, and other lesser peptides that contained phosphoserine.	Phosphoserine	338-351	insulin	Homo sapiens	82-89	
7542920-6	1995	Two-dimensional thin-layer tryptic mapping of the phosphorylated insulin receptor/insulin-stimulated insulin receptor serine kinase preparation or of insulin receptor phosphorylated in human Hep G2 cells yielded two major peptides, called S1 and S2, that ran as a pair of closely migrating spots, and other lesser peptides that contained phosphoserine.	Phosphoserine	338-351	insulin	Homo sapiens	82-89	
7542920-6	1995	Two-dimensional thin-layer tryptic mapping of the phosphorylated insulin receptor/insulin-stimulated insulin receptor serine kinase preparation or of insulin receptor phosphorylated in human Hep G2 cells yielded two major peptides, called S1 and S2, that ran as a pair of closely migrating spots, and other lesser peptides that contained phosphoserine.	Phosphoserine	338-351	insulin	Homo sapiens	82-89	
8216295-5	1993	These data suggest that phosphoserine and phosphothreonine on insulin receptor play an important role in insulin-induced conformational change of the receptor.	Phosphoserine	24-37	insulin	Homo sapiens	62-69	
2136851-2	1990	Analysis of the serine phosphate incorporated into partially purified or highly purified insulin receptor suggests that an insulin-sensitive serine kinase (IRSK) copurifies with the insulin receptor.	Phosphoserine	16-32	insulin	Homo sapiens	89-96	
1654905-2	1991	In vivo, insulin-stimulation resulted in the appearance of three phosphoserine-containing phosphopeptides and a distinct phosphothreonine peptide (threonine 1348).	Phosphoserine	65-78	insulin	Homo sapiens	9-16	
1691719-4	1990	In response to insulin, the phosphoserine and phosphothreonine content in p185HER-2 was transiently enhanced about 6-fold.	Phosphoserine	28-41	insulin	Homo sapiens	15-22	
1652474-3	1991	The major insulin-stimulated phosphoserine peptides were the same as those after PMA, with the exception of 2 minor phosphoserine peptides.	Phosphoserine	29-42	insulin	Homo sapiens	10-17	
2197270-7	1990	These findings indicate that insulin activates the serine/threonine kinase activity of the Raf-1 proto-oncogene by increasing its content of phosphoserine.	Phosphoserine	141-154	insulin	Homo sapiens	29-36	
2136851-4	1990	The major insulin-stimulated HPLC phosphopeptide peak from insulin receptors labeled in intact cells contains a hydrophilic phosphoserine-containing peptide which rapidly elutes from a C18 column.	Phosphoserine	124-137	insulin	Homo sapiens	10-17	
2136851-4	1990	The major insulin-stimulated HPLC phosphopeptide peak from insulin receptors labeled in intact cells contains a hydrophilic phosphoserine-containing peptide which rapidly elutes from a C18 column.	Phosphoserine	124-137	insulin	Homo sapiens	59-66	
33797881-3	2021	Herein, we describe the use of two ligation manifolds, namely, diselenide-selenoester ligation and native chemical ligation, to assemble a 31.5 kDa phosphorylated insulin-like growth factor binding protein (IGFBP-2) that comprises 290 amino acid residues, a phosphoserine post-translational modification, and nine disulfide bonds.	Phosphoserine	258-271	insulin	Homo sapiens	163-170	
2504716-9	1989	Phosphoamino acid analysis demonstrated that the phosphoserine/phosphothreonine content of in vivo 32P-labeled insulin receptors increased markedly within a 1-h exposure to insulin in vivo, whereas insulin-induced receptor desensitization was not apparent until 10-24 h after exposure to insulin.	Phosphoserine	49-62	insulin	Homo sapiens	111-118	
2504716-9	1989	Phosphoamino acid analysis demonstrated that the phosphoserine/phosphothreonine content of in vivo 32P-labeled insulin receptors increased markedly within a 1-h exposure to insulin in vivo, whereas insulin-induced receptor desensitization was not apparent until 10-24 h after exposure to insulin.	Phosphoserine	49-62	insulin	Homo sapiens	173-180	
2504716-9	1989	Phosphoamino acid analysis demonstrated that the phosphoserine/phosphothreonine content of in vivo 32P-labeled insulin receptors increased markedly within a 1-h exposure to insulin in vivo, whereas insulin-induced receptor desensitization was not apparent until 10-24 h after exposure to insulin.	Phosphoserine	49-62	insulin	Homo sapiens	173-180	
2504716-9	1989	Phosphoamino acid analysis demonstrated that the phosphoserine/phosphothreonine content of in vivo 32P-labeled insulin receptors increased markedly within a 1-h exposure to insulin in vivo, whereas insulin-induced receptor desensitization was not apparent until 10-24 h after exposure to insulin.	Phosphoserine	49-62	insulin	Homo sapiens	173-180	
3001088-8	1986	In IM-9 cells, insulin also increased the phosphoserine and possibly the phosphothreonine content of the beta subunit.	Phosphoserine	42-55	insulin	Homo sapiens	15-22	
6374655-9	1984	Thus, control of adipose tissue lipolysis by fast-acting lipolytic hormones and by insulin is exerted through the regulation of the phosphorylation state of a single phosphoserine residue in the hormone-sensitive lipase.	Phosphoserine	166-179	insulin	Homo sapiens	83-90	
6316966-2	1983	Phospho-amino acid analysis of the receptor subunit revealed that insulin increased at least 2.5-fold the content of phosphoserine and of phosphotyrosine.	Phosphoserine	117-130	insulin	Homo sapiens	66-73	
6316966-3	1983	In intact cells, the major effect of insulin is to increase the phosphoserine content of its receptor.	Phosphoserine	64-77	insulin	Homo sapiens	37-44	
6256361-4	1981	Only phosphoserine was found in S6 isolated from insulin-treated cells.	Phosphoserine	5-18	insulin	Homo sapiens	49-56